Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Author Correction: Droplet microfluidics for the highly controlled synthesis of branched gold nanoparticles

    Sara Abalde-Cela, Patricia Taladriz-Blanco in Scientific Reports (2022)

  2. Article

    Open Access

    Improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facility

    On 11th March 2020, the UK government announced plans for the scaling of COVID-19 testing, and on 27th March 2020 it was announced that a new alliance of private sector and academic collaborative laboratories ...

    Julie A. Douthwaite, Christopher A. Brown, John R. Ferdinand in Scientific Reports (2022)

  3. Article

    Open Access

    Inhibiting Mycobacterium tuberculosis CoaBC by targeting an allosteric site

    Coenzyme A (CoA) is a fundamental co-factor for all life, involved in numerous metabolic pathways and cellular processes, and its biosynthetic pathway has raised substantial interest as a drug target against m...

    Vitor Mendes, Simon R. Green, Joanna C. Evans, Jeannine Hess in Nature Communications (2021)

  4. Article

    Open Access

    Unexpected stability of aqueous dispersions of raspberry-like colloids

    Aqueous colloidal suspensions, both man-made and natural, are part of our everyday life. The applicability of colloidal suspensions, however, is limited by the range of conditions over which they are stable. H...

    Yang Lan, Alessio Caciagli, Giulia Guidetti, Ziyi Yu, Ji Liu in Nature Communications (2018)

  5. Article

    Open Access

    Droplet microfluidics for the highly controlled synthesis of branched gold nanoparticles

    The synthesis of anisotropic metallic nanoparticles (NPs) has been a field of intense and challenging research in the past decade. In this communication, we report on the reproducible and highly controllable s...

    Sara Abalde-Cela, Patricia Taladriz-Blanco in Scientific Reports (2018)

  6. Article

    Open Access

    Correction: Corrigendum: Surface mediated cooperative interactions of drugs enhance mechanical forces for antibiotic action

    Scientific Reports 7:Article number: 41206; published online: 03 February 2017; updated: 23 March 2017 This Article contains errors. An additional affiliation for Samadhan B. Patil was omitted. The correct aff...

    Joseph W. Ndieyira, Joe Bailey, Samadhan B. Patil, Manuel Vögtli in Scientific Reports (2017)

  7. Article

    Open Access

    Surface mediated cooperative interactions of drugs enhance mechanical forces for antibiotic action

    The alarming increase of pathogenic bacteria that are resistant to multiple antibiotics is now recognized as a major health issue fuelling demand for new drugs. Bacterial resistance is often caused by molecula...

    Joseph W. Ndieyira, Joe Bailey, Samadhan B. Patil, Manuel Vögtli in Scientific Reports (2017)

  8. No Access

    Protocol

    Antagonists of the miRNA-Argonaute 2 Protein Complex: Anti-miR-AGOs

    microRNAs (miRNAs) have been identified as high-value drug targets. A widely applied strategy in miRNA inhibition is the use of antisense agents. However, it has been shown that oligonucleotides are poorly cel...

    Marco F. Schmidt, Oliver Korb, Chris Abell in Drug Target miRNA (2017)

  9. No Access

    Article

    Small molecules, big targets: drug discovery faces the protein–protein interaction challenge

  10. Protein–protein interactions (PPIs) are increasingly being targeted by drug discovery groups, and there exists great scope for therapeutic modulation of this t...

  11. Duncan E. Scott, Andrew R. Bayly, Chris Abell in Nature Reviews Drug Discovery (2016)

  12. Article

    Open Access

    Structural characterization of CYP144A1 – a cytochrome P450 enzyme expressed from alternative transcripts in Mycobacterium tuberculosis

    Mycobacterium tuberculosis (Mtb) causes the disease tuberculosis (TB). The virulent Mtb H37Rv strain encodes 20 cytochrome P450 (CYP) enzymes, many of which are implicated in Mtb survival and pathogenicity in the...

    Jude Chenge, Madeline E. Kavanagh, Max D. Driscoll, Kirsty J. McLean in Scientific Reports (2016)

  13. No Access

    Article

    Interfacial assembly of dendritic microcapsules with host–guest chemistry

    The self-assembly of nanoscale materials to form hierarchically ordered structures promises new opportunities in drug delivery, as well as magnetic materials and devices. Herein, we report a simple means to pr...

    Yu Zheng, Ziyi Yu, Richard M. Parker, Yuchao Wu, Chris Abell in Nature Communications (2014)

  14. No Access

    Article

    Evolution of enzyme catalysts caged in biomimetic gel-shell beads

    Natural evolution relies on the improvement of biological entities by rounds of diversification and selection. In the laboratory, directed evolution has emerged as a powerful tool for the development of new an...

    Martin Fischlechner, Yolanda Schaerli, Mark F. Mohamed, Santosh Patil in Nature Chemistry (2014)

  15. No Access

    Article

    Surface-stress sensors for rapid and ultrasensitive detection of active free drugs in human serum

    There is a growing appreciation that mechanical signals can be as important as chemical and electrical signals in biology. To include such signals in a systems biology description for understanding pathobiolog...

    Joseph W. Ndieyira, Natascha Kappeler, Stephen Logan in Nature Nanotechnology (2014)

  16. No Access

    Article

    A three-stage biophysical screening cascade for fragment-based drug discovery

    This protocol describes the screening of a library of low-molecular-weight compounds (fragments) using a series of biophysical ligand-binding assays. Fragment-based drug discovery (FBDD) has emerged as a succe...

    Ellene H Mashalidis, Paweł Śledź, Steffen Lang, Chris Abell in Nature Protocols (2013)

  17. Article

    Open Access

    Tri-partite complex for axonal transport drug delivery achieves pharmacological effect

    Targeted delivery of pharmaceutical agents into selected populations of CNS (Central Nervous System) neurons is an extremely compelling goal. Currently, systemic methods are generally used for delivery of pain...

    Aaron G Filler, Garth T Whiteside, Mark Bacon, Martyn Frederickson in BMC Neuroscience (2010)

  18. No Access

    Chapter and Conference Paper

    Fragment-Based Drug Discovery in Academia: Experiences From a Tuberculosis Programme

    The problems associated with neglected diseases are often compounded by increasing incidence of antibiotic resistance. Patient negligence and abuse of antibiotics has lead to explosive growth in cases of tuber...

    Timo J. Heikkila, Sachin Surade, Hernani L. Silvestre in From Molecules to Medicines (2009)

  19. No Access

    Article

    Nanomechanical detection of antibiotic–mucopeptide binding in a model for superbug drug resistance

    The alarming growth of the antibiotic-resistant superbugs methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) is driving the development of new technologies to investiga...

    Joseph Wafula Ndieyira, Moyu Watari, Alejandra Donoso Barrera in Nature Nanotechnology (2008)

  20. No Access

    Article

    Towards engineering increased pantothenate (vitamin B5) levels in plants

    Pantothenate (vitamin B5) is the precursor of the 4′-phosphopantetheine moiety of coenzyme A and acyl-carrier protein. It is made by plants and microorganisms de novo, but is a dietary requirement for animals. Th...

    Ereck Chakauya, Katy M. Coxon, Ma Wei, Mary V. MacDonald in Plant Molecular Biology (2008)

  21. No Access

    Chapter and Conference Paper

    Cell Based Biological Assay Using Microfluidics

    A microfluidic device has been designed to measure and manipulate microdroplets, in which protein expression is induced in single cells. The device exploits the permeation of water through poly (dimethylsiloxa...

    Jung-uk Shim, Luis Olguin in EKC2008 Proceedings of the EU-Korea Confer… (2008)

  22. No Access

    Article

    High-throughput crystallography for lead discovery in drug design

  23. Knowledge of the three-dimensional structures of target proteins provides a starting point for structure-based approaches to drug design by defining the topogr...

  24. Tom L. Blundell, Harren Jhoti, Chris Abell in Nature Reviews Drug Discovery (2002)

previous disabled Page of 2